GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Total Stockholders Equity

Bioqual (Bioqual) Total Stockholders Equity : $22.05 Mil (As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual Total Stockholders Equity?

Bioqual's Total Stockholders Equity for the quarter that ended in May. 2018 was $22.05 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bioqual's Book Value per Share for the quarter that ended in May. 2018 was $24.65. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bioqual's Debt-to-Equity for the quarter that ended in May. 2018 was 0.01.


Bioqual Total Stockholders Equity Historical Data

The historical data trend for Bioqual's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Total Stockholders Equity Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.64 10.16 10.37 18.92 22.05

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.64 10.16 10.37 18.92 22.05

Bioqual  (OTCPK:BIOQ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bioqual's Book Value per Share for the quarter that ended in May. 2018 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bioqual's Debt-to-Equity for the quarter that ended in May. 2018 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioqual Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bioqual's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines